Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors

Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms

Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765 · see citing works

A comprehensive genetic map of the human genome based on 5,264 microsatellites

Dib, C., Fauré, S., Fizames, C., Samson, D. S., Drouot, N., Alain Vignal, A., Millasseau, P., Marc, S., Kazan, J., Seboun, E., et al. (1996) · Nature · doi:10.1038/380152a0 · Cited by 2,927 · see citing works

‘Touchdown’ PCR to circumvent spurious priming during gene amplification

Don, R. H., Cox, P. T., Wainwright, B. J., Baker, K. N., & Mattick, J. S. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.14.4008 · Cited by 2,586 · see citing works

A cancer family syndrome in twenty-four kindreds.

Li, F. P., Fraumeni, J. F., Mulvihill, J. J., Blattner, W. A., Dreyfus, M., Tucker, M., & Miller, R. (1988) · PubMed · Cited by 1,293 · see citing works

Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer.

Parsons, R. E., Myeroff, L. L., Liu, B., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1995) · PubMed · Cited by 738 · see citing works

Structural aspects of the p53 protein in relation to gene evolution.

Soussi, T., de Fromentel, C. C., & May, P. (1990) · PubMed · Cited by 608 · see citing works

Multiple Primary Cancers in Families With Li-Fraumeni Syndrome

Hisada, M., Garber, J. E., Li, F. P., Fung, C. Y., & Fraumeni, J. F. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.8.606 · Cited by 553 · see citing works

Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.

Bártek, J., Bártková, J., Vojtěšek, B., Stašková, Z., Lukáš, J., Rejthar, A., Kovařík, J., Midgley, C. A., Gannon, J., & Lane, D. P. (1991) · PubMed · Cited by 506 · see citing works

Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families

Birch, Hartley, Tricker, Prosser, P., Condie, Kelsey, Harris, Jones, Binchy, Crowther, et al. (1994) · Cancer Research · Cited by 475 · see citing works

Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.

Birch, J. M., Hartley, A. L., Tricker, K. J., Prosser, J., Condie, A., Kelsey, A. M., Harris, M., Jones, P. H. M., Binchy, A., & Crowther, D. (1994) · PubMed · Cited by 421 · see citing works

Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations

Bardeesy, N. M., Falkoff, D., Petruzzi, M. J., Nowak, N. J., Zabel, B., Adam, M., Aguiar, M. C., Grundy, P. E., Shows, T. B., & Pelletier, J. (1994) · Nature Genetics · doi:10.1038/ng0594-91 · Cited by 334 · see citing works

Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli

Midgley, C., Fisher, C., Bártek, J., Vojtěšek, B., Lane, D. P., & Barnes, D. M. (1992) · Journal of Cell Science · doi:10.1242/jcs.101.1.183 · Cited by 330 · see citing works

Frameshift mutator mutations

Malkhosyan, S. R., Rampino, N. J., Yamamoto, H., & Perucho, M. (1996) · Nature · doi:10.1038/382499a0 · Cited by 322 · see citing works

Tumours and hemihypertrophy associated with Wiedemann-Beckwith syndrome

Wiedemann, H. R. (1983) · European Journal of Pediatrics · doi:10.1007/bf00496807 · Cited by 281 · see citing works

Gene losses in human tumours

Ponder, B. A. J. (1988) · Nature · doi:10.1038/335400a0 · Cited by 279 · see citing works

Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.

Varley, J. M., McGown, G., Thorncroft, M. R., Santibanez‐Koref, M., Kelsey, A. M., Tricker, K. J., Evans, D. G., & Birch, J. M. (1997) · PubMed · Cited by 263 · see citing works

p53 Mutations Are Common and Early Events that Precede Tumor Invasion in Squamous Cell Neoplasia of the Skin

Campbell, C., Quinn, A., Ro, Y., Angus, B., & Rees, J. L. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12475717 · Cited by 227 · see citing works

High frequency of germline p53 mutations in childhood adrenocortical cancer

Wagner, J., Portwine, C., Rabin, K., Leclerc, J.-M., Narod, S. A., & Malkin, D. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.22.1707 · Cited by 227 · see citing works

Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome.

Frébourg, T., Barbier, N., Yan, Y.-X., Garber, J. E., Dreyfus, M., Fraumeni, J. F., Li, F. P., & Friend, S. H. (1995) · Europe PMC (PubMed Central) · Cited by 203 · see citing works

Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome

Birch, J. M., Blair, V., Kelsey, A. M., Evans, D. G., Harris, M., Tricker, K. J., & Varley, J. M. (1998) · Oncogene · doi:10.1038/sj.onc.1202033 · Cited by 200 · see citing works

p53 gene mutation: software and database

Béroud, C. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.1.147 · Cited by 187 · see citing works

p53 gene mutation: software and database

Béroud, C. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.1.200 · Cited by 149 · see citing works

Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma

Lohmann, D. R., Brandt, B., H�pping, W., Passarge, E., & Horsthemke, B. (1994) · Human Genetics · doi:10.1007/bf00201591 · Cited by 140 · see citing works

Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype.

Onadim, Z., Hogg, A., Baird, P. N., & Cowell, J. K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.6177 · Cited by 138 · see citing works

Overview of rb gene mutations in patients with retinoblastoma

Harbour, J. W. (1998) · Ophthalmology · doi:10.1016/s0161-6420(98)98025-3 · Cited by 117 · see citing works

Molecular Etiology of Low-Penetrance Retinoblastoma in Two Pedigrees

Dryja, T. P., Rapaport, J. M., McGee, T. L., Nork, T. M., & Schwartz, T. L. (1994) · Retina · doi:10.1097/00006982-199401000-00030 · Cited by 107 · see citing works

A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li – Fraumeni patients carrying a mutation to the TP53 gene

Varley, J. M., Thorncroft, M. R., McGown, G., Appleby, J. E., Kelsey, A. M., Tricker, K. J., Evans, D. G., & Birch, J. M. (1997) · Oncogene · doi:10.1038/sj.onc.1201041 · Cited by 105 · see citing works

Deletion of RBExons 24 and 25 Causes Low-Penetrance Retinoblastoma

Bremner, R., Du, D., Connolly-Wilson, M., Bridge, P. J., Ahmad, K. F., Mostachfi, H., Rushlow, D., Dunn, J. M., & Gallie, B. L. (1997) · The American Journal of Human Genetics · doi:10.1086/515499 · Cited by 102 · see citing works

Detection of Novel Germ-line p53 Mutations in Diverse-Cancer-Prone Families Identifiled by Selecting Patients With Childhood Adrencortical Carcinoma

Sameshima, Y., Tsunematsu, Y., Watanabe, S., Tsukamoto, T., Kawa‐Ha, K., Hirata, Y., Mizoguchi, H., Sugimura, T., Terada, M., & Yokota, J. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.9.703 · Cited by 91 · see citing works

An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53.

Varley, J. M., McGown, G., Thorncroft, M. R., Tricker, K. J., Teare, M. D., Santibanez‐Koref, M., Martin, J. W., Birch, J. M., & Evans, D. G. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.12.942 · Cited by 83 · see citing works

The p53 gene in pediatric therapy-related leukemia and myelodysplasia

Felix, C., Hosler, M. R., Provisor, D., Salhany, K., Sexsmith, E., Slater, D., Cheung, N., Winick, N., Strauss, E., Heyn, R. M., et al. (1996) · Blood · doi:10.1182/blood.v87.10.4376.bloodjournal87104376 · Cited by 79 · see citing works

Highly consistent genetic alterations in childhood adrenocortical tumours detected by comparative genomic hybridization

James, L. M., Kelsey, A. M., Birch, J. M., & Varley, J. M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6990691 · Cited by 75 · see citing works

ARCAD: A method for estimating age‐dependent disease risk associated with mutation carrier status from family data

Bihan-Benjamin, C. L., Moutou, C., Brugières, L., Feunteun, J., & Bonaïti‐Pellié, C. (1995) · Genetic Epidemiology · doi:10.1002/gepi.1370120103 · Cited by 61 · see citing works

Association of germline p53 mutation with MLL segmental jumping translocation in treatment-related leukemia.

Felix, C. A., Megonigal, M. D., Chervinsky, D. S., Leonard, D. G. B., Tsuchida, N., Kakati, S., Block, A. M. W., Fisher, J. E., Grossi, M., Salhany, K., et al. (1998) · PubMed · doi:10.1182/blood.v91.12.4451 · Cited by 57 · see citing works

Astrocytomas and Choroid Plexus Tumors in Two Families with Identical p53 Germline Mutations

Vital, A., Bringuier, P., Huang, H., Galli, F. S., Rivel, J., Ansoborlo, S., Jm, C., Taillandier, L., Kleihues, P., & Ohgaki, H. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199811000-00009 · Cited by 56 · see citing works

Genetic and functional studies of a germline TP53 splicing mutation in a Li–Fraumeni-like family

Varley, J. M., Chapman, P. J., McGown, G., Thorncroft, M. R., White, G. R. M., Greaves, M. J., Scott, D., Spreadborough, A. R., Tricker, K. J., Birch, J. M., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201878 · Cited by 52 · see citing works

A splicing mutation in RB1 in low penetrance retinoblastoma

Schubert, E. L., Strong, L. C., & Hansen, M. F. (1997) · Human Genetics · doi:10.1007/s004390050551 · Cited by 51 · see citing works

Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours

Sedláček, Z., Kodet, R., Kriz, V., Seemanová, E., Vodvarka, P., Wilgenbus, P., Mareš, J., Poustka, A. J., & Goetz, P. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.172 · Cited by 49 · see citing works

Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53

Birch, J. M., Heighway, J., Teare, M. D., Kelsey, A. M., Hartley, A. L., Tricker, K. J., Crowther, D., Lane, D. P., & Santibanez‐Koref, M. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.468 · Cited by 49 · see citing works

Germ-line splicing mutation of the p53 gene in a cancer-prone family.

Warneford, S., Witton, L. J., Townsend, M., Rowe, P. B., Reddel, R. R., Dalla‐Pozza, L., & Symonds, G. P. (1992) · PubMed · Cited by 46 · see citing works

Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation.

Horio, Y., Suzuki, H., Ueda, R., Koshikawa, T., Sugiura, T., Ariyoshi, Y., Shimokata, K., Takahashi, T., & Takahashi, T. (1994) · PubMed · Cited by 41 · see citing works

Simultaneous adrenocortical carcinoma and ganglioneuroblastoma in a child with Turner syndrome and germline p53 mutation.

Pivnick, E. K., Furman, W. L., Velagaleti, G. V. N., Jenkins, J. J., Chase, N. A., & Ribeiro, R. C. (1998) · Journal of Medical Genetics · doi:10.1136/jmg.35.4.328 · Cited by 40 · see citing works

Familial Brain Tumour Syndrome Associated with a p53 Germline Deletion of Codon 236

Lübbe, J., Ammon, K. V., Watanabe, K., Hegi, M. E., & Kleihues, P. (1995) · Brain Pathology · doi:10.1111/j.1750-3639.1995.tb00572.x · Cited by 32 · see citing works

A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm.

Felix, C. A., Strauss, E. A., D'Amico, D., Tsokos, M., Winter, S. C., Mitsudomi, T., Nau, M. M., Brown, D., Leahey, A., & Horowitz, M. (1993) · PubMed · Cited by 31 · see citing works

A de novo p53 germline mutation affecting codon 151 in a six year old child with multiple tumors

Gutiérrez, M. I., Bhatla, K. G., Berreiro, C., Spangler, G., Schvartzman, E., Muriel, F. S., & Magrath, L. T. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.12.2247 · Cited by 23 · see citing works

Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ

Munn, K., Walker, R. A., Menasce, L. P., & Varley, J. M. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.592 · Cited by 22 · see citing works

Novel germline mutation of the p53 tumor suppressor gene in a child with incidentally discovered adrenal cortical carcinoma.

Gh, G., Moore, S. L., Schneider, B., Saldivar, & Hensel, C. H. (1994) · PubMed · Cited by 21 · see citing works

Rapid Diagnosis of Germline p53 Mutation Using the Enzyme Mismatch Cleavage Method

Giunta, C., Youil, R., Venter, D. J., Chow, C. W., Somers, G. R., Lafferty, A. R. A., Kemper, B., & Cotton, R. G. H. (1996) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199612000-00007 · Cited by 18 · see citing works

Radiation-induced G1 arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations

Boyle, J. M., Greaves, M. J., Camplejohn, R. S., Birch, J. M., Roberts, S. A., & Varley, J. M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690265 · Cited by 17 · see citing works

Complex replication error causes p53 mutation in a Li-Fraumeni family.

Strauss, E. A., Hosler, M. R., Herzog, P., Salhany, K., Louie, R., & Felix, C. A. (1995) · PubMed · Cited by 16 · see citing works

A novel missense mutation in patients from a retinoblastoma pedigree showing only mild expression of the tumor phenotype

Cowell, J. K., & Bia, B. (1998) · Oncogene · doi:10.1038/sj.onc.1201833 · Cited by 15 · see citing works

Single base pair germ-line deletion in the p53 gene in a cancer predisposed family

Hamelin, R., Barichard, F., Henry, I., Junien, C., & Thomas, G. D. (1994) · Human Genetics · doi:10.1007/bf02272849 · Cited by 13 · see citing works

A novel deletion within exon 6 of TP53 in a family with Li-Fraumeni-like syndrome, and LOH in a benign lesion from a mutation carrier

Varley, J. M., Thorncroft, M. R., McGown, G., Tricker, K. J., Birch, J. M., & Evans, D. G. (1996) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(96)00059-3 · Cited by 13 · see citing works

Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family.

Stolzenberg, M., Brugières, L., Gardes, M., Dessarps-Freichey, F., Chompret, A., Paillerets, B. B., Lenoir, G., Bonaïti‐Pellié, C., Lemerle, J., & Feunteun, J. (1994) · PubMed · Cited by 13 · see citing works

Ophthalmic genetics: a genealogical guide to sources in England and Wales.

Jay, M. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.12.946 · Cited by 9 · see citing works

Untitled work

(1996) · doi:10.1002/(sici)1097-0142(19961001)78:7

Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis

Rivlin, N., Brosh, R., Oren, M., & Rotter, V. (2011) · Genes & Cancer · doi:10.1177/1947601911408889 · Cited by 1,033 · see citing works

Adrenocortical carcinoma

Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892 · see citing works

Revisiting Li-Fraumeni Syndrome From <i>TP53</i> Mutation Carriers

Bougeard, G., Renaux-Petel, M., Flaman, J.-M., Charbonnier, C., Fermey, P., Belotti, M., Gauthier-Villars, M., Stoppa-Lyonnet, D., Consolino, E., Brugières, L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.5728 · Cited by 760 · see citing works

Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations

Hagman, K. D. F., Noltner, K., Buzin, C. H., Gu, D., Wen, C. Y., Nguyen, V. Q., Han, J., Lowstuter, K. J., Longmate, J., Sommer, S. S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6959 · Cited by 607 · see citing works

A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment

Hampel, H., Bennett, R. L., Buchanan, A. H., Pearlman, R., & Wiesner, G. L. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.147 · Cited by 590 · see citing works

An inherited <i>p53</i> mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma

Ribeiro, R. C., Sandrini, F., Figueiredo, B., Zambetti, G. P., Michalkiewicz, E., Lafferty, A. R., DeLacerda, L., Rabin, M., Cadwell, C., Sampaio, G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161479898 · Cited by 541 · see citing works

Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome

Kratz, C. P., Achatz, M. I., Brugières, L., Frebourg, T., Garber, J. E., Greer, M.-L. C., Hansford, J. R., Janeway, K. A., Kohlmann, W. K., McGee, R., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0408 · Cited by 534 · see citing works

Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry

Michalkiewicz, E., Sandrini, R., Figueiredo, B., Miranda, E. C. M., Caran, E., Oliveira-Filho, A. G., Marques, R., Pianovski, M. A. D., Lacerda, L., Cristofani, L. M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.085 · Cited by 519 · see citing works

Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.

Olivier, M., Goldgar, D. E., Sodha, N., Ohgaki, H., Kleihues, P., Hainaut, P. L., & Eeles, R. A. (2003) · PubMed · Cited by 480 · see citing works

Relative frequency and morphology of cancers in carriers of germline TP53 mutations

Birch, J. M., Alston, R. D., McNally, R. J., Evans, D. G. R., Kelsey, A. M., Harris, M., Eden, O. B., & Varley, J. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204621 · Cited by 467 · see citing works

GermlineTP53 mutations and Li-Fraumeni syndrome

Varley, J. M. (2003) · Human Mutation · doi:10.1002/humu.10185 · Cited by 429 · see citing works

True

Chompret, A., Brugières, L., Abel, A. L. V., Lemerle, J., Ronsin, M., Gardes, M., Dessarps-Freichey, F., Feunteun, J., Hua, D., Ligot, L., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1167 · Cited by 372 · see citing works

Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes

The European Reference Network GENTURIS, Frébourg, T., Bajalica‐Lagercrantz, S., Oliveíra, C., Mágenheim, R., & Evans, D. G. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0638-4 · Cited by 344 · see citing works

Sensitivity and predictive value of criteria for p53germline mutation screening

Chompret, A., ABEL, A., Stoppa‐Lyonnet, D., Brugières, L., Pagès-Berhouet, S., Feunteun, J., & Bonaïti‐Pellié, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.1.43 · Cited by 336 · see citing works

TP53 germline mutation testing in 180 families suspected of Li–Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes

Ruijs, M., Verhoef, S., Rookus, M. A., Pruntel, R., van der Hout, A. H., Hogervorst, F. B. L., Kluijt, I., Sijmons, R. H., Aalfs, C. M., Wagner, A., et al. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.073429 · Cited by 304 · see citing works

Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes: Table 1

Evans, D. G., Birch, J. M., Ramsden, R. T., Sharif, S., & Baser, M. E. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.036319 · Cited by 299 · see citing works

Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center

Ayala‐Ramirez, M., Jasim, S., Feng, L., Ejaz, S., Denız, F., Busaidy, N. L., Waguespack, S. G., Naing, A., Sircar, K., Wood, C. G., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0519 · Cited by 294 · see citing works

Adrenocortical cancer: pathophysiology and clinical management

Libé, R., Fratticci, A., & Bertherat, J. Y. (2007) · Endocrine Related Cancer · doi:10.1677/erc.1.01130 · Cited by 271 · see citing works

Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.

Bertherat, J. Y., Groussin, L., Sandrini, F., Matyakhina, L., Bei, T. A., Stergiopoulos, S. G., Papageorgiou, T., Bourdeau, I., Kirschner, L. S., Vincent-Dejean, C., et al. (2003) · PubMed · Cited by 250 · see citing works

Epidemiology and genetics of childhood cancer

Stiller, C. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207717 · Cited by 243 · see citing works

Prevalence and Functional Consequence of TP53 Mutations in Pediatric Adrenocortical Carcinoma: A Children's Oncology Group Study

Wasserman, J. D., Novokmet, A., Eichler-Jonsson, C., Ribeiro, R. C., Galindo, C. R., Zambetti, G. P., & Malkin, D. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.6863 · Cited by 229 · see citing works

The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families

Achatz, M. I., Olivier, M., Calvez‐Kelm, F. L., Martel‐Planche, G., Lopes, A., Rossi, B. M., Ashton‐Prolla, P., Giugliani, R., Palmero, E. I., Vargas, F. R., et al. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.12.039 · Cited by 218 · see citing works

An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors

Latronico, A. C., Pinto, E. M., Domenice, S., Fragoso, M. C. B. V., Martin, R. M., Zerbini, M. C., Lucon, A. M., & Mendonca, B. B. (2001) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jcem.86.10.7957 · Cited by 224 · see citing works

Adrenocortical carcinoma is a Lynch syndrome-associated cancer

Raymond, V. M., Everett, J. N., Furtado, L. V., Gustafson, S. L., Jungbluth, C. R., Gruber, S. B., Hammer, G. D., Stoffel, E. M., Greenson, J. K., Giordano, T. J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.0988 · Cited by 208 · see citing works

Impact of Neonatal Screening and Surveillance for the <i>TP53</i> R337H Mutation on Early Detection of Childhood Adrenocortical Tumors

Custódio, G., Parise, G. A., Kiesel Filho, N., Komechen, H., Sabbaga, C. C., Rosati, R., Grisa, L., Parise, I. Z. S., Pianovski, M. A. D., Fiori, C. M. C. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3711 · Cited by 201 · see citing works

Multiple endocrine neoplasia type 1

Marini, F., Falchetti, A., Monte, F. D., Sala, S. C., Gozzini, A., Luzi, E., & Brandi, M. L. (2006) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-1-38 · Cited by 182 · see citing works

Development of adrenal cortex zonation

Xing, Y., Lerario, A. M., Rainey, W., & Hammer, G. D. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.001 · Cited by 174 · see citing works

Molecular genetics of adrenocortical tumours, from familial to sporadic diseases

Libé, R., & Bertherat, J. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02004 · Cited by 168 · see citing works

Referral for cancer genetics consultation: a review and compilation of risk assessment criteria

Hampel, H., Sweet, K., Westman, J. A., Offit, K., & Eng, C. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.010918 · Cited by 154 · see citing works

Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.

Dörk, T., Bendix, R., Bremer, M., Rades, D., Klöpper, K., Nicke, M., Skawran, B., Hector, A., Yamini, P., Steinmann, D., et al. (2001) · PubMed · Cited by 151 · see citing works

Biology, clinical characteristics, and management of adrenocortical tumors in children

Rodriguez‐Galindo, C., Figueiredo, B. C., Zambetti, G. P., & Ribeiro, R. C. (2005) · Pediatric Blood &amp; Cancer · doi:10.1002/pbc.20318 · Cited by 146 · see citing works

Comparative Genomic Hybridization Analysis of Adrenocortical Tumors

Sidhu, S. B., Marsh, D. J., Theodosopoulos, G., Philips, J. N., Bambach, C. P., Campbell, P. R., Magarey, C. J., Russell, C. F. J., Schulte, K., Röher, H. D., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8697 · Cited by 144 · see citing works

Childhood adrenocortical tumours

Ribeiro, R. C., & de Figueiredo, B. C. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.01.031 · Cited by 140 · see citing works

The International Pediatric Adrenocortical Tumor Registry initiative: Contributions to clinical, biological, and treatment advances in pediatric adrenocortical tumors

Ribeiro, R. C., Pinto, E. M., Zambetti, G. P., & Galindo, C. R. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.015 · Cited by 134 · see citing works

Molecular Markers and the Pathogenesis of Adrenocortical Cancer

Soon, P. S. H., McDonald, K. L., Robinson, B. G., & Sidhu, S. B. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0243 · Cited by 130 · see citing works

Therapeutic exploitation of the p53 pathway

Lane, D. P., & Laı́n, S. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02309-2 · Cited by 127 · see citing works

Predictors of survival in pediatric adrenocortical carcinoma: A Surveillance, Epidemiology, and End Results (SEER) program study

McAteer, J. P., Huaco, J. A., & Gow, K. W. (2013) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2013.02.017 · Cited by 127 · see citing works

Contribution of de novo and mosaic TP53 mutations to Li-Fraumeni syndrome

Renaux‐Petel, M., Charbonnier, F., Théry, J., Fermey, P., Lienard, G., Bou, J., Coutant, S., Vézain, M., Kasper, E., Fourneaux, S., et al. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-104976 · Cited by 124 · see citing works

Somatic <i>TP53</i> Mutations Are Relatively Rare among Adrenocortical Cancers with the Frequent 17p13 Loss of Heterozygosity

Libè, R., Groussin, L., Tissier, F., Elie, C., René-Corail, F., Fratticci, A., Jullian, E., Beck-Peccoz, P., Bertagna, X., Gicquel, C., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2085 · Cited by 115 · see citing works

Genetics and epigenetics of adrenocortical tumors

Lerário, A. M., Moraitis, A. G., & Hammer, G. D. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.10.028 · Cited by 112 · see citing works

<i>TP53</i>Germline Mutations in Adult Patients with Adrenocortical Carcinoma

Herrmann, L. J. M., Heinze, B., Fassnacht, M., Willenberg, H. S., Quinkler, M., Reisch, N., Zink, M., Allolio, B., & Hahner, S. (2012) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2011-1982 · Cited by 109 · see citing works

Tumor Protein p53 (TP53) Testing and Li-Fraumeni Syndrome

Sorrell, A., Espenschied, C. R., Culver, J. O., & Weitzel, J. N. (2013) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-013-0020-0 · Cited by 107 · see citing works

New targets and therapeutic approaches for endocrine malignancies☆

Fassnacht, M., Kreissl, M. C., Weismann, D., & Allolio, B. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.013 · Cited by 104 · see citing works

Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma

Raymond, V. M., Else, T., Everett, J. N., Long, J. M., Gruber, S. B., & Hammer, G. D. (2013) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2012-2198 · Cited by 105 · see citing works

Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium

Mai, P. L., Malkin, D. M., Garber, J. E., Schiffman, J. D., Weitzel, J. N., Strong, L. C., Wyss, O., Locke, L., Means, V., Achatz, M. I., et al. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.06.008 · Cited by 103 · see citing works

The Li–Fraumeni syndrome

Chompret, A. (2002) · Biochimie · doi:10.1016/s0300-9084(01)01361-x · Cited by 101 · see citing works

Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations

Krutilkova, V., Trková, M., Fleitz, J. M., Gregor, V., Novotna, K., Křepelová, A., Sumerauer, D., Kodet, R., Širůčková, S., Plevová, P., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.01.026 · Cited by 97 · see citing works

Adrenal Cortical Neoplasms in Children: Why So Many Carcinomas and Yet So Many Survivors?

Dehner, L. P., & Hill, D. A. (2009) · Pediatric and Developmental Pathology · doi:10.2350/08-06-0489.1 · Cited by 95 · see citing works

Adrenocortical Development, Maintenance, and Disease

Yates, R., Katugampola, H., Cavlan, D., Cogger, K., Meimaridou, E., Hughes, C. R., Metherell, L., Guasti, L., & King, P. (2013) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-416021-7.00007-9 · Cited by 90 · see citing works

GermlineTP53Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry

Yurgelun, M. B. B., Masciari, S., Joshi, V. A., Mercado, R. C., Lindor, N. M., Gallinger, S., Hopper, J. L., Jenkins, M. A., Buchanan, D. D., Newcomb, P. A., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.0197 · Cited by 88 · see citing works

Mechanisms of non-Mendelian inheritance in genetic disease

van Heyningen, V. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh254 · Cited by 86 · see citing works

Towards an understanding of the role of p53 in adrenocortical carcinogenesis

Wasserman, J. D., Zambetti, G. P., & Malkin, D. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.010 · Cited by 84 · see citing works

Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults

Faria, A. M., & Almeida, M. Q. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.040 · Cited by 80 · see citing works

Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients

Alsner, J., Yilmaz, M. K., Guldberg, P., Hansen, L. L., & Overgaard, J. (2000) · Breast Cancer Research · doi:10.1186/bcr109 · Cited by 78 · see citing works

Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1

Kumamoto, T., Yamazaki, F., Nakano, Y., Tamura, C., Tashiro, S., Hattori, H., Nakagawara, A., & Tsunematsu, Y. (2021) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-02011-w · Cited by 71 · see citing works

The p53 mutation “gradient effect” and its clinical implications

Zambetti, G. P. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21217 · Cited by 71 · see citing works

A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes

Scollon, S., Anglin, A. K., Thomas, M. H., Turner, J. T., & Schneider, K. W. (2017) · Journal of Genetic Counseling · doi:10.1007/s10897-017-0077-8 · Cited by 71 · see citing works

Risk assessment and management of high risk familial breast cancer

Evans, D. G., & Lalloo, F. I. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.12.865 · Cited by 69 · see citing works

Update on tumours of the adrenal cortex, phaeochromocytoma and extra‐adrenal paraganglioma

McNicol, A. M. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03613.x · Cited by 68 · see citing works

Pediatric adrenocortical tumours

Pinto, E. M., Zambetti, G. P., & Galindo, C. R. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101448 · Cited by 71 · see citing works

A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma

Davies, A. J., Lee, A. M., Taylor, C., Clear, A. J., Goff, L. K., Iqbal, S., Heavens, D., Calaminici, M., Norton, A. J., Lister, T. A., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403802 · Cited by 68 · see citing works

Mapping of the candidate tumor suppressor genes’ loci on human chromosome 3 in head and neck squamous cell carcinoma of an Indian patient population

Dasgupta, S., Mukherjee, N., Roy, S., Roy, A., Sengupta, A., Roychowdhury, S., & Panda, C. K. (2002) · Oral Oncology · doi:10.1016/s1368-8375(00)00131-7 · Cited by 67 · see citing works

Pediatric Adrenocortical Tumors: What They Can Tell Us on Adrenal Development and Comparison with Adult Adrenal Tumors

Lalli, E., & de Figueiredo, B. C. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00023 · Cited by 64 · see citing works

Molecular epidemiology of adrenocortical tumors in southern Brazil

Custódio, G., Komechen, H., Figueiredo, F. R. O., Fachin, N. D., Pianovski, M. A. D., & Figueiredo, B. C. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.019 · Cited by 63 · see citing works

Drastic Effect of GermlineTP53Missense Mutations in Li-Fraumeni Patients

Zerdoumi, Y., Aury‐Landas, J., Bonaïti‐Pellié, C., Derambure, C., Sesboüé, R., Renaux‐Petel, M., Frébourg, T., Bougeard, G., & Flaman, J. (2012) · Human Mutation · doi:10.1002/humu.22254 · Cited by 63 · see citing works

Characterization of germline TP53 splicing mutations and their genetic and functional analysis

Varley, J. M., Attwooll, C. L., White, G. R. M., McGown, G., Thorncroft, M. R., Kelsey, A. M., Greaves, M. J., Boyle, J. M., & Birch, J. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204369 · Cited by 62 · see citing works

Adrenocortical stem and progenitor cells: Implications for adrenocortical carcinoma

Simon, D. P., & Hammer, G. D. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.12.006 · Cited by 58 · see citing works

What 20 years of research has taught us about the TP53 p.R337H mutation

Pinto, E. M., & Zambetti, G. P. (2020) · Cancer · doi:10.1002/cncr.33143 · Cited by 59 · see citing works

Future directions in the diagnosis and medical treatment of adrenocortical carcinoma

Creemers, S. G., Hofland, L. J., Korpershoek, E., Franssen, G. J. H., van Kemenade, F. J., de Herder, W. W., & Feelders, R. A. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0452 · Cited by 59 · see citing works

Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, Brazil

Pianovski, M. A. D., Maluf, E. M. C. P., de Carvalho, D. S., Ribeiro, R. C., Rodriguez‐Galindo, C., Boffetta, P., Zancanella, P., & Figueiredo, B. C. (2006) · Pediatric Blood &amp; Cancer · doi:10.1002/pbc.20624 · Cited by 57 · see citing works

Contribution of genotoxic anticancer treatments to the development of multiple primary tumours in the context of germline TP53 mutations

Kasper, E., Angot, É., Colasse, É., Nicol, L., Sabourin, J., Adriouch, S., Lacoume, Y., Charbonnier, C., Raad, S., Frébourg, T., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.06.011 · Cited by 57 · see citing works

Clinical and molecular aspects of adrenocortical tumourigenesis

Sidhu, S. B., Gicquel, C., Bambach, C. P., Campbell, P. R., Magarey, C. J., Robinson, B. G., & Delbridge, L. (2003) · ANZ Journal of Surgery · doi:10.1046/j.1445-2197.2003.02746.x · Cited by 56 · see citing works

Two hits revisited again

Tomlinson, I. P. M., Roylance, R. R., & Houlston, R. S. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.2.81 · Cited by 56 · see citing works

SNP Array Profiling of Childhood Adrenocortical Tumors Reveals Distinct Pathways of Tumorigenesis and Highlights Candidate Driver Genes

Letouzé, É., Rosati, R., Komechen, H., Doghman, M., Marisa, L., Flück, C. E., de Krijger, R. R., van Noesel, M. M., Mas, J.-C., Pianovski, M. A. D., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1184 · Cited by 53 · see citing works

Transcriptome analysis of adrenocortical cancers (ACC): from molecular classification to the identification of new treatments

Ragazzon, B., Assié, G., & Bertherat, J. Y. (2011) · Endocrine Related Cancer · doi:10.1530/erc-10-0220 · Cited by 53 · see citing works

Adrenocortical tumors in Italian children: Analysis of clinical characteristics and P53 status. Data from the national registries

Dall’Igna, P., Virgone, C., Salvo, G. L. D., Bertorelle, R., Indolfi, P., Paoli, A. D., Buffa, P., Conte, M., Esposito, G., Inserra, A., et al. (2014) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2014.03.006 · Cited by 53 · see citing works

Pathogenesis of adrenocortical cancer

Bertherat, J. Y., & BERTAGNA, X. Y. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.006 · Cited by 55 · see citing works

The Role of P53 in Human Cancer

Malkin, D. M. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010636426860 · Cited by 52 · see citing works

Adrenocortical tumors and hyperplasias in childhood--etiology, genetics, clinical presentation and therapy.

Sutter, J. A., & Grimberg, A. (2006) · PubMed · Cited by 51 · see citing works

Adrenocortical cancer: recent clinical and molecular advances

Sidhu, S. B., Sywak, M. S., Robinson, B. G., & Delbridge, L. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200401000-00004 · Cited by 51 · see citing works

Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population

Mitra, S., Banerjee, S., Misra, C., Singh, R. K., Roy, A., Sengupta, A., Panda, C. K., & Roychoudhury, S. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.034835 · Cited by 50 · see citing works

Genetics of adrenocortical tumors: gatekeepers, landscapers and conductors in symphony

Stratakis, C. A. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2003.08.005 · Cited by 50 · see citing works

TP53-Associated Pediatric Malignancies

Pinto, E. M., Ribeiro, R. C., de Figueiredo, B. C., & Zambetti, G. P. (2011) · Genes & Cancer · doi:10.1177/1947601911409745 · Cited by 49 · see citing works

Identification of Clinical and Biologic Correlates Associated With Outcome in Children With Adrenocortical Tumors Without Germline TP53 Mutations: A St Jude Adrenocortical Tumor Registry and Children’s Oncology Group Study

Pinto, E. M., Galindo, C. R., Pounds, S. B., Wang, L., Clay, M. R., Neale, G. A. M., Garfinkle, E. A. R., Lam, C. G., Levy, C. F., Pappo, A. S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.2460 · Cited by 51 · see citing works

Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome

Evans, D. G., Birch, J. M., Thorneycroft, M., McGown, G., Lalloo, F. I., & Varley, J. M. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.12.941 · Cited by 49 · see citing works

Pediatric adrenocortical carcinoma

Ilanchezhian, M., Varghese, D. G., Glod, J. W., Reilly, K. M., Widemann, B. C., Pommier, Y. G., Kaplan, R. N., & Rivero, J. D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.961650 · Cited by 49 · see citing works

Germline TP53 pathogenic variants and breast cancer: A narrative review

Blondeaux, E., Arecco, L., Punie, K., Graffeo, R., Toss, A., Angelis, C. D., Trevisan, L., Buzzatti, G., Linn, S. C., Dubsky, P. C., et al. (2023) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2023.102522 · Cited by 47 · see citing works

Malignant adrenal tumors

Rescorla, F. J. (2006) · Seminars in Pediatric Surgery · doi:10.1053/j.sempedsurg.2005.11.008 · Cited by 47 · see citing works

Adrenal Cortical Carcinoma—Review of Current Knowledge and Treatment Practices

Phan, A. T. (2007) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2007.04.007 · Cited by 45 · see citing works

TP53, hChk2, and the Li-Fraumeni Syndrome

Varley, J. M. (2003) · Humana Press eBooks · doi:10.1385/1-59259-328-3:117 · Cited by 43 · see citing works

Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer

Steinmann, D., Bremer, M., Rades, D., Skawran, B., Siebrands, C., Karstens, J. H., & Dörk, T. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2016 · Cited by 46 · see citing works

Mechanisms of Disease: adrenocortical tumors—molecular advances and clinical perspectives

Bertherat, J. Y., Groussin, L., & BERTAGNA, X. Y. (2006) · Nature Clinical Practice Endocrinology &#38 Metabolism · doi:10.1038/ncpendmet0321 · Cited by 40 · see citing works

Adrenal gland and other paraganglia

(2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06969-4.00011-8 · Cited by 37 · see citing works

Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors

Mastellaro, M. J., Seidinger, A. L., Kang, G., Abrahão, R., MIRANDA, E. C. M., Pounds, S. B., Cardinalli, I. A., Aguiar, S. S., de Figueiredo, B. C., Galindo, C. R., et al. (2017) · Cancer · doi:10.1002/cncr.30703 · Cited by 36 · see citing works

Germline TP53 Testing in Breast Cancers: Why, When and How?

Evans, D. G., Woodward, E. R., Bajalica‐Lagercrantz, S., Oliveíra, C., & Frébourg, T. (2020) · Cancers · doi:10.3390/cancers12123762 · Cited by 36 · see citing works

The molecular basis of adrenocortical cancer

Lehmann, T. P., & Wrzesiński, T. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.02.009 · Cited by 34 · see citing works

p53 + /mdm2 − Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma in Young Children: An Early Expression of Li-Fraumeni Syndrome

Debelenko, L. V., Pérez‐Atayde, A. R., DuBois, S. G., Grier, H. E., Pai, S., Shamberger, R. C., & Kozakewich, H. P. (2009) · Pediatric and Developmental Pathology · doi:10.2350/09-08-0694-oa.1 · Cited by 35 · see citing works

Toward Efficient Analysis of Mutations in Single Cells from Ethanol-Fixed, Paraffin-Embedded, and Immunohistochemically Stained Tissues

Heinmöller, E., Liu, Q., Sun, Y., Schlake, G., Hill, K. A., Weiss, L. M., & Sommer, S. S. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780437 · Cited by 35 · see citing works

Pediatric adrenocortical tumor – review and management update

Balderrama-Brondani, V., & Fragoso, M. C. B. V. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000540 · Cited by 35 · see citing works

Identification of a Novel Germ Line Variant Hotspot Mutant p53-R175L in Pediatric Adrenal Cortical Carcinoma

West, A. N., Ribeiro, R. C., Jenkins, J., Galindo, C. R., de Figueiredo, B. C., Kriwacki, R. W., & Zambetti, G. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4580 · Cited by 34 · see citing works

High frequency of germline p53 mutations in childhood adrenocortical cancer

Wagner, J., Portwine, C., Rabin, K., Leclerc, J.-M., Narod, S. A., & Malkin, D. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.22.1707 · Cited by 227 · see citing works

CLINICAL GENETICS doi: 10.1111/j.1399-0004.2012.01841.x

Genet, C., Wiley, J., Razalie, H., Rahman, E. A., & Paediatrics, C.-O. U. (2016)

Inherited germline TP53 mutation encodes a protein with an aberrant C-terminal motif in a case of pediatric adrenocortical tumor

Pinto, E. M., Ribeiro, R. C., Kletter, G. B., Lawrence, J. P., Jenkins, J. J., Wang, J., Shurtleff, S. A., McGregor, L. M., Kriwacki, R. W., & Zambetti, G. P. (2010) · Familial Cancer · doi:10.1007/s10689-010-9392-z · Cited by 21 · see citing works

Childhood adrenocortical carcinoma as a sentinel cancer for detecting families with germline TP53 mutations

Choong, S. S., Latiff, Z. A., Mohamed, M. B., Lim, L. L., Chen, K., Vengidasan, L., Razali, H., Rahman, E. A., Ariffin, H., & for Malaysian Society of Paediatric Haematology‐Oncology (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01841.x · Cited by 22 · see citing works

Prevalence and Functional Consequence of TP53 Mutations in Pediatric Adrenocortical Carcinoma: A Children's Oncology Group Study

Wasserman, J. D., Novokmet, A., Eichler-Jonsson, C., Ribeiro, R. C., Galindo, C. R., Zambetti, G. P., & Malkin, D. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.6863 · Cited by 229 · see citing works